Melting dsDNA Donor Molecules Vastly Improves Precision Genome Enhancing in Caenorhabditiselegans
CRISPR genome modifying has revolutionized genetics in numerous organisms. Inside the nematode Caenorhabditiselegans one injection into each of the two gonad arms of an grownup hermaphrodite exposes tons of of meiotic germ cells to modifying mixtures, permitting the restoration of a lot of indels or small precision edits from each effectively injected animal. Sadly, considerably for prolonged insertions, modifying efficiencies can differ broadly, necessitating a lot of injections, and generally requiring co-selection strategies.
Proper right here we current that melting double stranded DNA (dsDNA) donor molecules earlier to injection will improve the frequency of tangible homology-directed restore (HDR) by a lot of fold for longer edits. We describe troubleshooting strategies that permit persistently extreme modifying efficiencies ensuing, as an illustration, in as a lot as 100 unbiased GFP knock-ins from a single injected animal. These efficiencies make C. elegans by far the best metazoan to genome edit, eradicating limitations to the use and adoption of this facile system as a model for understanding animal biology.
Water-Pipe Smoking Publicity Deregulates a Set of Genes Associated to Human Head and Neck Most cancers Development and Prognosis
- Water-pipe smoking (WPS) is popping into probably the most well-liked sort of tobacco use among the many many youth, notably inside the Heart East, altering cigarettes rapidly and turning into a critical risk of tobacco dependancy worldwide. Smoke from WPS accommodates comparable toxins as these present in cigarette smoke and is linked immediately with a number of kinds of cancers along with lung and head and neck (HN) carcinomas.
- Nonetheless, the underlying molecular pathways and/or purpose genes accountable for the carcinogenic course of are nonetheless unknown. On this study, human common oral epithelial (HNOE) cells, NanoStringPanCancer Pathways panel of 770 gene transcripts and quantitative real-time polymerase chain response (qRT-PCR) analysis had been utilized to seek out differentially expressed genes (DEG) modulated by WPS. In silico analysis was carried out to research the affect of these genes in HN most cancers affected particular person’s biology and consequence. We found that WPS can induce the epithelial-mesenchymal transition (EMT: hallmark of most cancers growth) of HNOE cells.
- Further significantly, our analysis of NanoString revealed 23 genes deregulated beneath the affect of WPS, accountable for the modulation of cell cycle, proliferation, migration/invasion, apoptosis, signal transduction, and inflammatory response. Extra analysis was carried out using qRT-PCR of HNOE WPS-exposed and unexposed cells supported the reliability of our NanoString info.
- Moreover, we exhibit these DEG to be upregulated in most cancers in distinction with common tissue. Using the Kaplan-Meier analysis, we seen a significant affiliation between WPS-deregulated genes and relapse-free survival/complete survival in HN most cancers victims. Our findings point out that WPS can modulate EMT along with a set of genes which could be immediately involved in human HN carcinogenesis, thereby affecting HN most cancers victims’ survival.
Vav 1 Oncogene (VAV1) Polyclonal Antibody |
|||
MBS2032848-02mL | MyBiosource | 0.2mL | EUR 220 |
Vav 1 Oncogene (VAV1) Polyclonal Antibody |
|||
MBS2032848-05mL | MyBiosource | 0.5mL | EUR 365 |
Vav 1 Oncogene (VAV1) Polyclonal Antibody |
|||
MBS2032848-1mL | MyBiosource | 1mL | EUR 445 |
Vav 1 Oncogene (VAV1) Polyclonal Antibody |
|||
MBS2032848-5mL | MyBiosource | 5mL | EUR 1220 |
Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
PAC213Hu01 | Cloud-Clone | 100ul | EUR 245 |
|
Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
PAC213Mu01 | Cloud-Clone | 100ul | EUR 252 |
|
Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2027967-01mL | MyBiosource | 0.1mL | EUR 175 |
Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2027967-02mL | MyBiosource | 0.2mL | EUR 220 |
Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2027967-05mL | MyBiosource | 0.5mL | EUR 355 |
Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2027967-1mL | MyBiosource | 1mL | EUR 435 |
Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2027967-5mL | MyBiosource | 5mL | EUR 1185 |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human) |
|||
4-PAC213Hu01 | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1) |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse) |
|||
4-PAC213Mu01 | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1) |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), PE |
|||
4-PAC213Hu01-PE | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with PE. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), PE |
|||
4-PAC213Mu01-PE | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with PE. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), APC |
|||
4-PAC213Hu01-APC | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with APC. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), Cy3 |
|||
4-PAC213Hu01-Cy3 | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with Cy3. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), HRP |
|||
4-PAC213Hu01-HRP | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with HRP. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), APC |
|||
4-PAC213Mu01-APC | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with APC. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), Cy3 |
|||
4-PAC213Mu01-Cy3 | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with Cy3. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), HRP |
|||
4-PAC213Mu01-HRP | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with HRP. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), FITC |
|||
4-PAC213Hu01-FITC | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with FITC. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), FITC |
|||
4-PAC213Mu01-FITC | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with FITC. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), Biotinylated |
|||
4-PAC213Hu01-Biotin | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with Biotin. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), Biotinylated |
|||
4-PAC213Mu01-Biotin | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with Biotin. |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064027-01mL | MyBiosource | 0.1mL | EUR 265 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064027-02mL | MyBiosource | 0.2mL | EUR 355 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064027-05mL | MyBiosource | 0.5mL | EUR 660 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064027-1mL | MyBiosource | 1mL | EUR 810 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064027-5mL | MyBiosource | 5mL | EUR 2330 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064033-01mL | MyBiosource | 0.1mL | EUR 275 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064033-02mL | MyBiosource | 0.2mL | EUR 365 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064033-05mL | MyBiosource | 0.5mL | EUR 675 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064033-1mL | MyBiosource | 1mL | EUR 835 |
PE-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064033-5mL | MyBiosource | 5mL | EUR 2395 |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Human), APC-Cy7 |
|||
4-PAC213Hu01-APC-Cy7 | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Human Vav 1 Oncogene (VAV1). This antibody is labeled with APC-Cy7. |
Vav 1 Oncogene (VAV1) Polyclonal Antibody (Mouse), APC-Cy7 |
|||
4-PAC213Mu01-APC-Cy7 | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Mouse Vav 1 Oncogene (VAV1). This antibody is labeled with APC-Cy7. |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064028-01mL | MyBiosource | 0.1mL | EUR 265 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064028-02mL | MyBiosource | 0.2mL | EUR 355 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064028-05mL | MyBiosource | 0.5mL | EUR 660 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064028-1mL | MyBiosource | 1mL | EUR 810 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064028-5mL | MyBiosource | 5mL | EUR 2330 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064029-01mL | MyBiosource | 0.1mL | EUR 265 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064029-02mL | MyBiosource | 0.2mL | EUR 355 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064029-05mL | MyBiosource | 0.5mL | EUR 660 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064029-1mL | MyBiosource | 1mL | EUR 810 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064029-5mL | MyBiosource | 5mL | EUR 2330 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064031-01mL | MyBiosource | 0.1mL | EUR 205 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064031-02mL | MyBiosource | 0.2mL | EUR 255 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064031-05mL | MyBiosource | 0.5mL | EUR 450 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064031-1mL | MyBiosource | 1mL | EUR 545 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064031-5mL | MyBiosource | 5mL | EUR 1530 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064034-01mL | MyBiosource | 0.1mL | EUR 275 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064034-02mL | MyBiosource | 0.2mL | EUR 365 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064034-05mL | MyBiosource | 0.5mL | EUR 675 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064034-1mL | MyBiosource | 1mL | EUR 835 |
APC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064034-5mL | MyBiosource | 5mL | EUR 2395 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064035-01mL | MyBiosource | 0.1mL | EUR 275 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064035-02mL | MyBiosource | 0.2mL | EUR 365 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064035-05mL | MyBiosource | 0.5mL | EUR 675 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064035-1mL | MyBiosource | 1mL | EUR 835 |
Cy3-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064035-5mL | MyBiosource | 5mL | EUR 2395 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064037-01mL | MyBiosource | 0.1mL | EUR 205 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064037-02mL | MyBiosource | 0.2mL | EUR 260 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064037-05mL | MyBiosource | 0.5mL | EUR 460 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064037-1mL | MyBiosource | 1mL | EUR 560 |
HRP-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064037-5mL | MyBiosource | 5mL | EUR 1570 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064030-01mL | MyBiosource | 0.1mL | EUR 215 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064030-02mL | MyBiosource | 0.2mL | EUR 265 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064030-05mL | MyBiosource | 0.5mL | EUR 480 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064030-1mL | MyBiosource | 1mL | EUR 585 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064030-5mL | MyBiosource | 5mL | EUR 1645 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064036-01mL | MyBiosource | 0.1mL | EUR 220 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064036-02mL | MyBiosource | 0.2mL | EUR 275 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064036-05mL | MyBiosource | 0.5mL | EUR 490 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064036-1mL | MyBiosource | 1mL | EUR 600 |
FITC-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064036-5mL | MyBiosource | 5mL | EUR 1690 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2094291-01mL | MyBiosource | 0.1mL | EUR 185 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2094291-02mL | MyBiosource | 0.2mL | EUR 230 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2094291-05mL | MyBiosource | 0.5mL | EUR 385 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2094291-1mL | MyBiosource | 1mL | EUR 470 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2094291-5mL | MyBiosource | 5mL | EUR 1300 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2094292-01mL | MyBiosource | 0.1mL | EUR 190 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2094292-02mL | MyBiosource | 0.2mL | EUR 230 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2094292-05mL | MyBiosource | 0.5mL | EUR 395 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2094292-1mL | MyBiosource | 1mL | EUR 485 |
Biotin-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2094292-5mL | MyBiosource | 5mL | EUR 1335 |
APC/CY7-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064026-1mL | MyBiosource | 1mL | EUR 1185 |
APC/CY7-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064026-5mL | MyBiosource | 5mL | EUR 3445 |
APC/CY7-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064026-5x5mL | MyBiosource | 5x5mL | EUR 15495 |
APC/CY7-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064032-1mL | MyBiosource | 1mL | EUR 1220 |
APC/CY7-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064032-5mL | MyBiosource | 5mL | EUR 3540 |
APC/CY7-Linked Polyclonal Antibody to Vav 1 Oncogene (VAV1) |
|||
MBS2064032-5x5mL | MyBiosource | 5x5mL | EUR 15930 |
Vav 1 Oncogene (VAV1) Antibody |
|||
20-abx128450 | Abbexa |
|
|
|
Vav 1 Oncogene (VAV1) Antibody |
|||
20-abx131502 | Abbexa |
|
|
|
Vav 1 Oncogene (VAV1) Antibody |
|||
abx332110-100ul | Abbexa | 100 ul | EUR 510 |
|
Vav 1 Oncogene (VAV1) Antibody |
|||
20-abx327434 | Abbexa |
|
|
|
Vav 1 Oncogene (VAV1) Antibody |
|||
20-abx327966 | Abbexa |
|
|
|
Vav 1 Oncogene (VAV1) Antibody |
|||
20-abx329103 | Abbexa |
|
|
|
Vav 1 Oncogene (VAV1) Antibody |
|||
abx331549-100ul | Abbexa | 100 ul | EUR 510 |
|
Vav 1 Oncogene (VAV1) Antibody |
|||
abx327434-100g | Abbexa | 100 µg | EUR 250 |
Vav 1 Oncogene (VAV1) Antibody |
|||
abx327434-50g | Abbexa | 50 µg | EUR 187.5 |
Vav 1 Oncogene (VAV1) Antibody |
|||
abx327966-100g | Abbexa | 100 µg | EUR 250 |
Vav 1 Oncogene (VAV1) Antibody |
|||
abx327966-50g | Abbexa | 50 µg | EUR 187.5 |
Vav 1 Oncogene (VAV1) Antibody |
|||
abx329103-100l | Abbexa | 100 µl | EUR 187.5 |
Vav 3 Oncogene (VAV3) Polyclonal Antibody |
|||
CAU22609-100ul | Biomatik Corporation | 100ul | EUR 235.2 |
Vav 3 Oncogene (VAV3) Polyclonal Antibody |
|||
CAU22609-200ul | Biomatik Corporation | 200ul | EUR 294 |
Vav 3 Oncogene (VAV3) Polyclonal Antibody |
|||
CAU22610-100ul | Biomatik Corporation | 100ul | EUR 235.2 |
Vav 3 Oncogene (VAV3) Polyclonal Antibody |
|||
CAU22610-200ul | Biomatik Corporation | 200ul | EUR 294 |
Polyclonal Antibody to Vav 3 Oncogene (VAV3) |
|||
PAE929Hu01 | Cloud-Clone | 100ul | EUR 245 |
|
A pilot study on the genetic vary of Mycobacterium tuberculosis difficult strains from tuberculosis victims inside the Littoral space of Cameroon
Background: The re-emergence of tuberculosis (TB) worldwide, compounded by multi-drug resistance (MDR) of the causative brokers constitutes a significant issue to the administration of the sickness. Speedy evaluation and proper stress identification are pivotal to the administration of the sickness. This pilot study investigated the genetic vary of Mycobacterium tuberculosis difficult (MTBC) strains from TB victims inside the Littoral space of Cameroon along with their resistance to rifampicin (RIF).
Victims and techniques: This was a cross sectional hospital-based study carried out between January and December 2017 and along with 158 isolates from sputum smear constructive folks [105 (66.5%) males and 53 (33.5%) females]. Sputum samples had been examined using Xpert MTB/RIF, adopted by custom on Lowenstein-Jensen medium. Isolates had been further subjected to molecular characterization using IS6110 typing, deletion analysis and spoligotyping.
Outcomes: 13 (8.8%) of the 147 isolates with susceptibility outcomes accessible had been proof towards RIF. Drug resistance occurred in 5/50 (10%) female compared with 8/97 (8.2%) male (OR, 0.81; 0.25-2.62; p = 0.764), and there was no very important distinction all through the age ranges (p = 0.448). Nonetheless, RIF resistance was associated (OR, 0.18, 95%CI, 0.05-0.69; p = 0.023) with beforehand dealt with victims [(4/14 (28.6%)] compared with new ones [9/133 (6.8%)].
The 150 acknowledged lineages included amongst others 54 (36%) Cameroon, 18 (12%) UgandaI, 32 (21.3%) Haarlem, 17 (11.3%) Ghana, 9(6%) West African 1, 7(4.7%) Delhi/CAS, 4 (2.7%) LAM and three (2%) UgandaII. Of the 150 isolates, a very powerful cluster was the Cameroon SIT 61, with 43(28.7%) isolates. Six (35.3%) of the 17 UgandaI sub-lineage had been RIF resistant (OR, 9.58; 95%CI, 2.74-33.55, p = 0.001).
Conclusion: The cosmopolitan Littoral space presents with a big Mycobacterium tuberculosis (MTB) strains vary and the UgandaI sub-lineage attainable associated to RIF resistance. Understanding the unfold of this clade by means of surveillance will enhance TB administration inside the space.
Pim-1 Oncogene (PIM1) Polyclonal Antibody | |||
CAU24102-200ul | Biomatik Corporation | 200ul | EUR 294 |
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
PAC578Hu01 | Cloud-Clone | 100ul | EUR 245 |
|
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
PAC578Mu01 | Cloud-Clone | 100ul | EUR 252 |
|
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
PAC578Ra01 | Cloud-Clone | 100ul | EUR 266 |
|
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2002188-01mL | MyBiosource | 0.1mL | EUR 175 |
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2002188-02mL | MyBiosource | 0.2mL | EUR 220 |
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2002188-05mL | MyBiosource | 0.5mL | EUR 355 |
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2002188-1mL | MyBiosource | 1mL | EUR 435 |
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2002188-5mL | MyBiosource | 5mL | EUR 1185 |
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2002793-01mL | MyBiosource | 0.1mL | EUR 175 |
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2002793-02mL | MyBiosource | 0.2mL | EUR 220 |
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2002793-05mL | MyBiosource | 0.5mL | EUR 365 |
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2002793-1mL | MyBiosource | 1mL | EUR 445 |
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2002793-5mL | MyBiosource | 5mL | EUR 1220 |
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2004826-01mL | MyBiosource | 0.1mL | EUR 180 |
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2004826-02mL | MyBiosource | 0.2mL | EUR 225 |
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2004826-05mL | MyBiosource | 0.5mL | EUR 380 |
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2004826-1mL | MyBiosource | 1mL | EUR 465 |
Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2004826-5mL | MyBiosource | 5mL | EUR 1285 |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Rat) | |||
4-PAC578Ra01 | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Rat Pim-1 Oncogene (PIM1) |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Mouse) | |||
4-PAC578Mu01 | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Mouse Pim-1 Oncogene (PIM1) |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Rat), PE | |||
4-PAC578Ra01-PE | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Rat Pim-1 Oncogene (PIM1). This antibody is labeled with PE. |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Rat), APC | |||
4-PAC578Ra01-APC | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Rat Pim-1 Oncogene (PIM1). This antibody is labeled with APC. |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Rat), Cy3 | |||
4-PAC578Ra01-Cy3 | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Rat Pim-1 Oncogene (PIM1). This antibody is labeled with Cy3. |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Rat), HRP | |||
4-PAC578Ra01-HRP | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Rat Pim-1 Oncogene (PIM1). This antibody is labeled with HRP. |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Mouse), PE | |||
4-PAC578Mu01-PE | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Mouse Pim-1 Oncogene (PIM1). This antibody is labeled with PE. |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Rat), FITC | |||
4-PAC578Ra01-FITC | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Rat Pim-1 Oncogene (PIM1). This antibody is labeled with FITC. |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Mouse), APC | |||
4-PAC578Mu01-APC | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Mouse Pim-1 Oncogene (PIM1). This antibody is labeled with APC. |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Mouse), Cy3 | |||
4-PAC578Mu01-Cy3 | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Mouse Pim-1 Oncogene (PIM1). This antibody is labeled with Cy3. |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Mouse), HRP | |||
4-PAC578Mu01-HRP | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Mouse Pim-1 Oncogene (PIM1). This antibody is labeled with HRP. |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Mouse), FITC | |||
4-PAC578Mu01-FITC | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Mouse Pim-1 Oncogene (PIM1). This antibody is labeled with FITC. |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Rat), Biotinylated | |||
4-PAC578Ra01-Biotin | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Rat Pim-1 Oncogene (PIM1). This antibody is labeled with Biotin. |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Mouse), Biotinylated | |||
4-PAC578Mu01-Biotin | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Mouse Pim-1 Oncogene (PIM1). This antibody is labeled with Biotin. |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Rat), APC-Cy7 | |||
4-PAC578Ra01-APC-Cy7 | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Rat Pim-1 Oncogene (PIM1). This antibody is labeled with APC-Cy7. |
PE-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066795-01mL | MyBiosource | 0.1mL | EUR 265 |
PE-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066795-02mL | MyBiosource | 0.2mL | EUR 355 |
PE-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066795-05mL | MyBiosource | 0.5mL | EUR 660 |
PE-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066795-1mL | MyBiosource | 1mL | EUR 810 |
PE-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066795-5mL | MyBiosource | 5mL | EUR 2330 |
PE-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066801-01mL | MyBiosource | 0.1mL | EUR 275 |
PE-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066801-02mL | MyBiosource | 0.2mL | EUR 365 |
PE-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066801-05mL | MyBiosource | 0.5mL | EUR 675 |
PE-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066801-1mL | MyBiosource | 1mL | EUR 835 |
PE-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066801-5mL | MyBiosource | 5mL | EUR 2395 |
PE-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066807-01mL | MyBiosource | 0.1mL | EUR 285 |
PE-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066807-02mL | MyBiosource | 0.2mL | EUR 380 |
PE-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066807-05mL | MyBiosource | 0.5mL | EUR 710 |
PE-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066807-1mL | MyBiosource | 1mL | EUR 875 |
PE-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066807-5mL | MyBiosource | 5mL | EUR 2525 |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Human, Mouse, Rat) | |||
4-PAC578Hu01 | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Human, Mouse, Rat Pim-1 Oncogene (PIM1) |
Pim-1 Oncogene (PIM1) Polyclonal Antibody (Mouse), APC-Cy7 | |||
4-PAC578Mu01-APC-Cy7 | Cloud-Clone |
|
|
|
|||
Description: A Rabbit polyclonal antibody against Mouse Pim-1 Oncogene (PIM1). This antibody is labeled with APC-Cy7. |
APC-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066796-01mL | MyBiosource | 0.1mL | EUR 265 |
APC-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066796-02mL | MyBiosource | 0.2mL | EUR 355 |
APC-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066796-05mL | MyBiosource | 0.5mL | EUR 660 |
APC-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066796-1mL | MyBiosource | 1mL | EUR 810 |
APC-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066796-5mL | MyBiosource | 5mL | EUR 2330 |
Cy3-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066797-01mL | MyBiosource | 0.1mL | EUR 265 |
Cy3-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066797-02mL | MyBiosource | 0.2mL | EUR 355 |
Cy3-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066797-05mL | MyBiosource | 0.5mL | EUR 660 |
Cy3-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066797-1mL | MyBiosource | 1mL | EUR 810 |
Cy3-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066797-5mL | MyBiosource | 5mL | EUR 2330 |
HRP-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066799-01mL | MyBiosource | 0.1mL | EUR 205 |
HRP-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066799-02mL | MyBiosource | 0.2mL | EUR 255 |
HRP-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066799-05mL | MyBiosource | 0.5mL | EUR 450 |
HRP-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066799-1mL | MyBiosource | 1mL | EUR 545 |
HRP-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066799-5mL | MyBiosource | 5mL | EUR 1530 |
APC-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066802-01mL | MyBiosource | 0.1mL | EUR 275 |
APC-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066802-02mL | MyBiosource | 0.2mL | EUR 365 |
APC-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066802-05mL | MyBiosource | 0.5mL | EUR 675 |
APC-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066802-1mL | MyBiosource | 1mL | EUR 835 |
APC-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066802-5mL | MyBiosource | 5mL | EUR 2395 |
Cy3-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066803-01mL | MyBiosource | 0.1mL | EUR 275 |
Cy3-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066803-02mL | MyBiosource | 0.2mL | EUR 365 |
Cy3-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066803-05mL | MyBiosource | 0.5mL | EUR 675 |
Cy3-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066803-1mL | MyBiosource | 1mL | EUR 835 |
Cy3-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066803-5mL | MyBiosource | 5mL | EUR 2395 |
HRP-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066805-01mL | MyBiosource | 0.1mL | EUR 205 |
HRP-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066805-02mL | MyBiosource | 0.2mL | EUR 260 |
HRP-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066805-05mL | MyBiosource | 0.5mL | EUR 460 |
HRP-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066805-1mL | MyBiosource | 1mL | EUR 560 |
HRP-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066805-5mL | MyBiosource | 5mL | EUR 1570 |
APC-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066808-01mL | MyBiosource | 0.1mL | EUR 285 |
APC-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066808-02mL | MyBiosource | 0.2mL | EUR 380 |
APC-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066808-05mL | MyBiosource | 0.5mL | EUR 710 |
APC-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066808-1mL | MyBiosource | 1mL | EUR 875 |
APC-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066808-5mL | MyBiosource | 5mL | EUR 2525 |
Cy3-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066809-01mL | MyBiosource | 0.1mL | EUR 285 |
Cy3-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066809-02mL | MyBiosource | 0.2mL | EUR 380 |
Cy3-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066809-05mL | MyBiosource | 0.5mL | EUR 710 |
Cy3-Linked Polyclonal Antibody to Pim-1 Oncogene (PIM1) | |||
MBS2066809-1mL | MyBiosource | 1mL | EUR 875 |